{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:00:41Z","timestamp":1793826041757,"version":"4.6.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s12325-021-01758-y","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T04:16:29Z","timestamp":1621311389000},"page":"3465-3482","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Patients with Congenital Low-Flow Vascular Malformation Treated with Low Dose Sirolimus"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0428-3242","authenticated-orcid":false,"given":"Veroniek E. M.","family":"Harbers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard A. P. J. M.","family":"Rongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine J. M.","family":"van der Vleuten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas H.","family":"Verhoeven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C. J.","family":"de Laat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal M. A. M.","family":"van der Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willemijn M.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo J.","family":"Schultze Kool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Maroeska W. M. te","family":"Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,18]]},"reference":[{"issue":"1","key":"1758_CR1","doi-asserted-by":"publisher","first-page":"e203","DOI":"10.1542\/peds.2014-3673","volume":"136","author":"M Wassef","year":"2015","unstructured":"Wassef M, Blei F, Adams D, et al. Vascular anomalies classification: recommendations from the international society for the study of vascular anomalies. Pediatrics. 2015;136(1):e203\u201314.","journal-title":"Pediatrics"},{"issue":"1035","key":"1758_CR2","doi-asserted-by":"publisher","first-page":"20130392","DOI":"10.1259\/bjr.20130392","volume":"87","author":"PR Mulligan","year":"2014","unstructured":"Mulligan PR, Prajapati HJ, Martin LG, Patel TH. Vascular anomalies: classification, imaging characteristics and implications for interventional radiology treatment approaches. Br J Radiol. 2014;87(1035):20130392.","journal-title":"Br J Radiol"},{"issue":"2","key":"1758_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1055\/s-0034-1376263","volume":"28","author":"JA Cox","year":"2014","unstructured":"Cox JA, Bartlett E, Lee EI. Vascular malformations: a review. Semin Plast Surg. 2014;28(2):58\u201363.","journal-title":"Semin Plast Surg"},{"issue":"3","key":"1758_CR4","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.1097\/GOX.0000000000000079","volume":"2","author":"S Akita","year":"2014","unstructured":"Akita S, Houbara S, Hirano A. Management of vascular malformations. Plast Reconstr Surg Glob Open. 2014;2(3):e128.","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"8","key":"1758_CR5","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/gcc.22739","volume":"58","author":"RW Ten Broek","year":"2019","unstructured":"Ten Broek RW, Eijkelenboom A, van der Vleuten CJM, et al. Comprehensive molecular and clinicopathological analysis of vascular malformations: a study of 319 cases. Genes Chromosomes Cancer. 2019;58(8):541\u201350.","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"1758_CR6","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/ajmg.a.36836","volume":"167A","author":"KM Keppler-Noreuil","year":"2015","unstructured":"Keppler-Noreuil KM, Rios JJ, Parker VE, et al. PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation. Am J Med Genet A. 2015;167A(2):287\u201395.","journal-title":"Am J Med Genet A"},{"issue":"4","key":"1758_CR7","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.3390\/genes5041064","volume":"5","author":"D Freed","year":"2014","unstructured":"Freed D, Stevens EL, Pevsner J. Somatic mosaicism in the human genome. Genes (Basel). 2014;5(4):1064\u201394.","journal-title":"Genes (Basel)"},{"issue":"9","key":"1758_CR8","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1172\/JCI76004","volume":"125","author":"E Boscolo","year":"2015","unstructured":"Boscolo E, Limaye N, Huang L, et al. Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects. J Clin Invest. 2015;125(9):3491\u2013504.","journal-title":"J Clin Invest"},{"issue":"1","key":"1758_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.det.2016.07.001","volume":"35","author":"N Nathan","year":"2017","unstructured":"Nathan N, Keppler-Noreuil KM, Biesecker LG, Moss J, Darling TN. Mosaic disorders of the PI3K\/PTEN\/AKT\/TSC\/mTORC1 signaling pathway. Dermatol Clin. 2017;35(1):51\u201360.","journal-title":"Dermatol Clin"},{"issue":"1","key":"1758_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","volume":"12","author":"DA Guertin","year":"2007","unstructured":"Guertin DA, Sabatini DM. Defining the role of mTOR in cancer. Cancer Cell. 2007;12(1):9\u201322.","journal-title":"Cancer Cell"},{"issue":"Pt 20","key":"1758_CR11","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1242\/jcs.051011","volume":"122","author":"M Laplante","year":"2009","unstructured":"Laplante M, Sabatini DM. mTOR signaling at a glance. J Cell Sci. 2009;122(Pt 20):3589\u201394.","journal-title":"J Cell Sci"},{"issue":"7","key":"1758_CR12","first-page":"813","volume":"42","author":"LS Nguyen","year":"2019","unstructured":"Nguyen LS, Vautier M, Allenbach Y, et al. Sirolimus and mTOR inhibitors: a review of side effects and specific management in solid organ transplantation. Drug Saf. 2019;42(7):813\u201325.","journal-title":"Drug Saf"},{"issue":"6","key":"1758_CR13","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/pbc.23124","volume":"57","author":"AM Hammill","year":"2011","unstructured":"Hammill AM, Wentzel M, Gupta A, et al. Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer. 2011;57(6):1018\u201324.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"1758_CR14","doi-asserted-by":"publisher","first-page":"e20153257","DOI":"10.1542\/peds.2015-3257","volume":"137","author":"DM Adams","year":"2016","unstructured":"Adams DM, Trenor CC 3rd, Hammill AM, et al. Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies. Pediatrics. 2016;137(2):e20153257.","journal-title":"Pediatrics"},{"issue":"12","key":"1758_CR15","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1007\/s00431-015-2572-y","volume":"174","author":"H Lackner","year":"2015","unstructured":"Lackner H, Karastaneva A, Schwinger W, et al. Sirolimus for the treatment of children with various complicated vascular anomalies. Eur J Pediatr. 2015;174(12):1579\u201384.","journal-title":"Eur J Pediatr"},{"issue":"1","key":"1758_CR16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13023-018-0934-z","volume":"13","author":"J Hammer","year":"2018","unstructured":"Hammer J, Seront E, Duez S, et al. Sirolimus is efficacious in treatment for extensive and\/or complex slow-flow vascular malformations: a monocentric prospective phase II study. Orphanet J Rare Dis. 2018;13(1):191.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"1758_CR17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.transproceed.2006.10.219","volume":"39","author":"C Morath","year":"2007","unstructured":"Morath C, Schwenger V, Ksoll-Rudek D, et al. Four cases of sirolimus-associated interstitial pneumonitis: identification of risk factors. Transplant Proc. 2007;39(1):99\u2013102.","journal-title":"Transplant Proc"},{"issue":"24","key":"1758_CR18","first-page":"1815","volume":"343","author":"SJ Singer","year":"2000","unstructured":"Singer SJ, Tiernan R, Sullivan EJ. Interstitial pneumonitis associated with sirolimus therapy in renal-transplant recipients. N Engl J Med. 2000;343(24):1815\u20136.","journal-title":"N Engl J Med"},{"issue":"1","key":"1758_CR19","doi-asserted-by":"publisher","first-page":"124 e1","DOI":"10.1016\/j.ajem.2014.05.047","volume":"33","author":"WL Wang","year":"2015","unstructured":"Wang WL, Yu LX. Acute respiratory distress attributed to sirolimus in solid organ transplant recipients. Am J Emerg Med. 2015;33(1):124 e1-134.","journal-title":"Am J Emerg Med"},{"key":"1758_CR20","doi-asserted-by":"crossref","unstructured":"Rossler J, Baselga E, Davila V, et al. Severe adverse events during sirolimus \"off-label\" therapy for vascular anomalies. Pediatr Blood Cancer. 2021:e28936.","DOI":"10.1002\/pbc.28936"},{"issue":"2","key":"1758_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1034\/j.1399-0012.2000.140201.x","volume":"14","author":"BD Kahan","year":"2000","unstructured":"Kahan BD, Napoli KL, Kelly PA, et al. Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity. Clin Transplant. 2000;14(2):97\u2013109.","journal-title":"Clin Transplant"},{"issue":"8","key":"1758_CR22","doi-asserted-by":"publisher","first-page":"e26470","DOI":"10.1002\/pbc.26470","volume":"64","author":"T Mizuno","year":"2017","unstructured":"Mizuno T, Fukuda T, Emoto C, et al. Developmental pharmacokinetics of sirolimus: implications for precision dosing in neonates and infants with complicated vascular anomalies. Pediatr Blood Cancer. 2017;64(8):e26470.","journal-title":"Pediatr Blood Cancer"},{"key":"1758_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ijporl.2017.11.034","volume":"105","author":"JA Czechowicz","year":"2018","unstructured":"Czechowicz JA, Long-Boyle JR, Rosbe KW, Mathes EF, Frieden IJ, Shimano KA. Sirolimus for management of complex vascular anomalies\u2014a proposed dosing regimen for very young infants. Int J Pediatr Otorhinolaryngol. 2018;105:48\u201351.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"7","key":"1758_CR24","doi-asserted-by":"publisher","first-page":"505","DOI":"10.7326\/0003-4819-144-7-200604040-00009","volume":"144","author":"L Champion","year":"2006","unstructured":"Champion L, Stern M, Israel-Biet D, et al. Brief communication: sirolimus-associated pneumonitis: 24 cases in renal transplant recipients. Ann Intern Med. 2006;144(7):505\u20139.","journal-title":"Ann Intern Med"},{"issue":"2","key":"1758_CR25","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/TP.0b013e3181927a41","volume":"87","author":"FP Schena","year":"2009","unstructured":"Schena FP, Pascoe MD, Alberu J, et al. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. Transplantation. 2009;87(2):233\u201342.","journal-title":"Transplantation"},{"issue":"6","key":"1758_CR26","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.transproceed.2009.06.003","volume":"41","author":"A Rodriguez-Moreno","year":"2009","unstructured":"Rodriguez-Moreno A, Ridao N, Garcia-Ledesma P, et al. Sirolimus and everolimus induced pneumonitis in adult renal allograft recipients: experience in a center. Transplant Proc. 2009;41(6):2163\u20135.","journal-title":"Transplant Proc"},{"issue":"5","key":"1758_CR27","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/j.1399-0012.2005.00356.x","volume":"19","author":"S Garrean","year":"2005","unstructured":"Garrean S, Massad MG, Tshibaka M, Hanhan Z, Caines AE, Benedetti E. Sirolimus-associated interstitial pneumonitis in solid organ transplant recipients. Clin Transplant. 2005;19(5):698\u2013703.","journal-title":"Clin Transplant"},{"key":"1758_CR28","doi-asserted-by":"crossref","unstructured":"Maschmeyer G, De Greef J, Mellinghoff SC, et al. Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL). Leukemia. 2019;33(4):844\u201362.","DOI":"10.1038\/s41375-019-0388-x"},{"issue":"1","key":"1758_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.otc.2017.09.006","volume":"51","author":"A Queisser","year":"2018","unstructured":"Queisser A, Boon LM, Vikkula M. Etiology and genetics of congenital vascular lesions. Otolaryngol Clin N Am. 2018;51(1):41\u201353.","journal-title":"Otolaryngol Clin N Am"},{"issue":"4","key":"1758_CR30","doi-asserted-by":"publisher","first-page":"448","DOI":"10.2340\/00015555-2300","volume":"96","author":"M Nadal","year":"2016","unstructured":"Nadal M, Giraudeau B, Tavernier E, Jonville-Bera AP, Lorette G, Maruani A. Efficacy and safety of mammalian target of rapamycin inhibitors in vascular anomalies: a systematic review. Acta Derm Venereol. 2016;96(4):448\u201352.","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"1758_CR31","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1136\/thoraxjnl-2017-210872","volume":"73","author":"J Bee","year":"2018","unstructured":"Bee J, Fuller S, Miller S, Johnson SR. Lung function response and side effects to rapamycin for lymphangioleiomyomatosis: a prospective national cohort study. Thorax. 2018;73(4):369\u201375.","journal-title":"Thorax"},{"issue":"5","key":"1758_CR32","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/s41436-018-0297-9","volume":"21","author":"VER Parker","year":"2019","unstructured":"Parker VER, Keppler-Noreuil KM, Faivre L, et al. Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum. Genet Med. 2019;21(5):1189\u201398.","journal-title":"Genet Med"},{"issue":"10","key":"1758_CR33","doi-asserted-by":"publisher","first-page":"e45868","DOI":"10.1371\/journal.pone.0045868","volume":"7","author":"M Braun","year":"2012","unstructured":"Braun M, Young J, Reiner CS, et al. Low-dose oral sirolimus and the risk of menstrual-cycle disturbances and ovarian cysts: analysis of the randomized controlled SUISSE ADPKD trial. PLoS One. 2012;7(10):e45868.","journal-title":"PLoS One"},{"issue":"22","key":"1758_CR34","doi-asserted-by":"publisher","first-page":"3748","DOI":"10.2174\/092986712801661130","volume":"19","author":"DA Altomare","year":"2012","unstructured":"Altomare DA, Khaled AR. Homeostasis and the importance for a balance between AKT\/mTOR activity and intracellular signaling. Curr Med Chem. 2012;19(22):3748\u201362.","journal-title":"Curr Med Chem"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01758-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-021-01758-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01758-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T03:50:39Z","timestamp":1623297039000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-021-01758-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,18]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["1758"],"URL":"https:\/\/doi.org\/10.1007\/s12325-021-01758-y","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,18]]},"assertion":[{"value":"22 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}